|
|
Blood, 15 October 2005, Vol. 106, No. 8, pp. 2884-2889.
Prepublished online as a Blood First Edition Paper on July 5, 2005; DOI 10.1182/blood-2005-05-1845.
Previous Article | Next Article 
Submitted May 6, 2005
Accepted June 20, 2005
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
Lan Lin, Y. Paul Goldberg, and Tomas Ganz*
Departments of Medicine and Pathology, David Geffen School of Medicine, Los Angeles, CA, USA
Xenon Pharmaceuticals Inc., Burnaby, BC, Canada
* Corresponding author; email: tganz{at}mednet.ucla.edu.
Mutations in a recently identified gene HJV (also called HFE2, or repulsive guidance molecule C, RgmC) are the major cause of juvenile hemochromatosis (JH). The protein product of HJV, hemojuvelin, contains a C-terminal GPI-anchor, suggesting that it can be present in either a soluble or a cell-associated form. Patients with HJV hemochromatosis have low urinary levels of hepcidin, the principal iron-regulatory hormone secreted by the liver. However, neither the specific role of hemojuvelin in maintaining iron homeostasis, nor its relationship to hepcidin has been experimentally established. In this study we used hemojuvelin-specific siRNAs to vary hemojuvelin mRNA concentration, and showed that cellular hemojuvelin positively regulated hepcidin mRNA expression, independently of the IL-6 pathway. We also showed that recombinant soluble hemojuvelin (rs-hemojuvelin) suppressed hepcidin mRNA expression in primary human hepatocytes in a log-linear dose-dependent manner, suggesting binding competition between soluble and cell-associated hemojuvelin. Soluble hemojuvelin was found in human sera at concentrations similar to those required to suppress hepcidin mRNA in vitro. In cells engineered to express hemojuvelin, soluble hemojuvelin release was progressively inhibited by increasing iron concentrations. We propose that soluble and cell-associated hemojuvelin reciprocally regulate hepcidin expression in response to changes in extracellular iron concentration.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A.-S. Zhang, F. Yang, J. Wang, H. Tsukamoto, and C. A. Enns
Hemojuvelin-Neogenin Interaction Is Required for Bone Morphogenic Protein-4-induced Hepcidin Expression
J. Biol. Chem.,
August 21, 2009;
284(34):
22580 - 22589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Ramsay, J. D. Hooper, A. R. Folgueras, G. Velasco, and C. Lopez-Otin
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis
Haematologica,
June 1, 2009;
94(6):
840 - 849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ramey, J.-C. Deschemin, and S. Vaulont
Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes
Haematologica,
June 1, 2009;
94(6):
765 - 772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Maxson, C. A. Enns, and A.-S. Zhang
Processing of hemojuvelin requires retrograde trafficking to the Golgi in HepG2 cells
Blood,
February 19, 2009;
113(8):
1786 - 1793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Truksa, P. Lee, and E. Beutler
Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness
Blood,
January 15, 2009;
113(3):
688 - 695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jiao, J. Wilkinson IV, X. Di, W. Wang, H. Hatcher, N. D. Kock, R. D'Agostino Jr, M. A. Knovich, F. M. Torti, and S. V. Torti
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator
Blood,
January 8, 2009;
113(2):
462 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Camaschella and L. Silvestri
New and old players in the hepcidin pathway
Haematologica,
October 1, 2008;
93(10):
1441 - 1444.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pagani, L. Silvestri, A. Nai, and C. Camaschella
Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response
Haematologica,
October 1, 2008;
93(10):
1466 - 1472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Folgueras, F. M. de Lara, A. M. Pendas, C. Garabaya, F. Rodriguez, A. Astudillo, T. Bernal, R. Cabanillas, C. Lopez-Otin, and G. Velasco
Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis
Blood,
September 15, 2008;
112(6):
2539 - 2545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-S. Zhang, F. Yang, K. Meyer, C. Hernandez, T. Chapman-Arvedson, P. J. Bjorkman, and C. A. Enns
Neogenin-mediated Hemojuvelin Shedding Occurs after Hemojuvelin Traffics to the Plasma Membrane
J. Biol. Chem.,
June 20, 2008;
283(25):
17494 - 17502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xia, J. L. Babitt, Y. Sidis, R. T. Chung, and H. Y. Lin
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin
Blood,
May 15, 2008;
111(10):
5195 - 5204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kuns-Hashimoto, D. Kuninger, M. Nili, and P. Rotwein
Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin
Am J Physiol Cell Physiol,
April 1, 2008;
294(4):
C994 - C1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Silvestri, A. Pagani, and C. Camaschella
Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
Blood,
January 15, 2008;
111(2):
924 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lin, E. V. Valore, E. Nemeth, J. B. Goodnough, V. Gabayan, and T. Ganz
Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4
Blood,
September 15, 2007;
110(6):
2182 - 2189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Silvestri, A. Pagani, C. Fazi, G. Gerardi, S. Levi, P. Arosio, and C. Camaschella
Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis
Blood,
May 15, 2007;
109(10):
4503 - 4510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-S. Zhang, S. A. Anderson, K. R. Meyers, C. Hernandez, R. S. Eisenstein, and C. A. Enns
Evidence That Inhibition of Hemojuvelin Shedding in Response to Iron Is Mediated through Neogenin
J. Biol. Chem.,
April 27, 2007;
282(17):
12547 - 12556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Constante, D. Wang, V.-A. Raymond, M. Bilodeau, and M. M. Santos
Repression of Repulsive Guidance Molecule C during Inflammation Is Independent of Hfe and Involves Tumor Necrosis Factor-{alpha}
Am. J. Pathol.,
February 1, 2007;
170(2):
497 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rodriguez, P. Pan, and S. Parkkila
Expression Studies of Neogenin and Its Ligand Hemojuvelin in Mouse Tissues
J. Histochem. Cytochem.,
January 1, 2007;
55(1):
85 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Christiansen, N. Sheikh, B. Saile, F. Reuter, M. Rave-Frank, R. M. Hermann, J. Dudas, A. Hille, C. F. Hess, and G. Ramadori
x-Irradiation in Rat Liver: Consequent Upregulation of Hepcidin and Downregulation of Hemojuvelin and Ferroportin-1 Gene Expression
Radiology,
December 1, 2006;
242(1):
189 - 197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K Mueller, T. Yamashita, G. Schaffar, and R. Mueller
The role of repulsive guidance molecules in the embryonic and adult vertebrate central nervous system
Phil Trans R Soc B,
September 29, 2006;
361(1473):
1513 - 1529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kuninger, R. Kuns-Hashimoto, R. Kuzmickas, and P. Rotwein
Complex biosynthesis of the muscle-enriched iron regulator RGMc
J. Cell Sci.,
August 15, 2006;
119(16):
3273 - 3283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Swinkels, M. C.H. Janssen, J. Bergmans, and J. J.M. Marx
Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Clin. Chem.,
June 1, 2006;
52(6):
950 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Donovan, C. N. Roy, and N. C. Andrews
The Ins and Outs of Iron Homeostasis
Physiology,
April 1, 2006;
21(2):
115 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Pietrangelo
Molecular insights into the pathogenesis of hereditary haemochromatosis.
Gut,
April 1, 2006;
55(4):
564 - 568.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Nemeth, G. C. Preza, C.-L. Jung, J. Kaplan, A. J. Waring, and T. Ganz
The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study
Blood,
January 1, 2006;
107(1):
328 - 333.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|